EXODUS-2, MURINE
EXODUS-2, MURINE结构式
|
常用名 | EXODUS-2, MURINE | 英文名 | EXODUS-2, MURINE |
|---|---|---|---|---|
| CAS号 | 196414-88-7 | 分子量 | N/A | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | N/A | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | N/A |
| 英文名 | EXODUS-2, MURINE |
|---|
| 外观性状 | lyophilized powder |
|---|---|
| 储存条件 | −20°C |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
|
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.
Mol. Cancer 2 , 22, (2004) SLC/CCL21, normally expressed in high endothelial venules and in T cell zones of spleen and lymph nodes, strongly attracts T cells and dendritic cells (DC). We have previously shown that SLC/CCL21-med... |
|
|
Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
Mol. Cancer 12 , 153, (2014) Secondary lymphoid tissue chemokine (SLC) is a key CC chemokine for chemotaxis of immune cells and has been an attractive candidate for anti-tumor treatments. However, among the immune cells recruited... |
|
|
Migratory properties of naive, effector, and memory CD8(+) T cells.
J. Exp. Med. 194 , 953-66, (2001) It has been proposed that two different antigen-experienced T cell subsets may be distinguishable by their preferential ability to home to lymphoid organs (central memory cells) or nonlymphoid tissues... |
